| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 7 |
| 1 | CYCLOPHOSPHAMIDE | 6 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 4 | DOXORUBICIN | 6 |
| 5 | PREDNISOLONE | 5 |
| 6 | PREDNISOLONE ORAL | 5 |
| 7 | PREDNISOLONE ORAL SOLUTION | 5 |
| 8 | METHOTREXATE SODIUM | 4 |
| 9 | AXICABTAGENE CILOLEUCEL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 1 | AXICABTAGENE CILOLEUCEL | 3 | 0.0003 |
| 2 | VINCRISTINE SULFATE | 3 | 0.0001 |
| 3 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| 4 | DOXORUBICIN HYDROCHLORIDE | 3 | 0.0001 |
| 5 | DOXORUBICIN | 6 | 0.0001 |
| 6 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 7 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 8 | ETOPOSIDE | 3 | 0.0000 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 3 | 0.0003 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 7 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 7 | 0.0000 |
| 5 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 9 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 3 | 0.0000 |